Skip to main content
. 2023 Mar 2;30(3):2978–2996. doi: 10.3390/curroncol30030227

Figure 3.

Figure 3

Overlap between the lists of DML (FDR 0.05) in BRAF mutant patients (light green), BRAF wild-type patients (light blue), and the methylation markers with significant (p ≤ 0.05) interaction for “tissue x mutation” in ANOVA (in pink).